Support our work
Decorative header background

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

Publication year 2012
Published in British Journal of Ophthalmology
Authors R.J. Van Geest, S.Y. Lesnik-Oberstein, H.S. Tan, M. Mura, R. Goldschmeding, C.J. Van Noorden, I. Klaassen, R.O. Schlingemann

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work